Vaxart’s Oral COVID-19 Vaccine Candidate Selected by ‘Operation Warp Speed’ for Testing

Vaxart Inc. has announced that its lead COVID-19 oral vaccine candidate has been chosen to participate in the US Federal government’s Operation Warp Speed program. Under the initiative, the vaccine will be tested in a non-human primate (NHP) challenge study.